Brown Seaweed May Have Potential as a Breast Cancer Preventive

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 12
Volume 8
Issue 12

DALLAS-Consumption of seaweed and soy may contribute to the lower rates of postmenopausal breast cancer seen in Japan, and seaweed/soy supplementation could be a potential cancer preventive in this country, Jane Teas, PhD, of the University of South Carolina, said at the Susan G. Komen Foundation National Grant Conference.

DALLAS—Consumption of seaweed and soy may contribute to the lower rates of postmenopausal breast cancer seen in Japan, and seaweed/soy supplementation could be a potential cancer preventive in this country, Jane Teas, PhD, of the University of South Carolina, said at the Susan G. Komen Foundation National Grant Conference.

In a preliminary study of healthy postmenopausal women, Dr. Teas found that use of seaweed and soy supplements affected the women’s hormone levels.

In this study, 12 healthy postmenopausal women, half of whom had been treated for early breast cancer, received 5 g/d of a low-iodine brown seaweed supplement (Alaria esculenta) for 6 weeks and seaweed plus a powdered soy supplement for 21 weeks. The results suggest a synergistic interaction between seaweed and soy, she said.

“Of particular interest in our study was the change in urinary estrogen metabolites associated with cancer,” Dr. Teas said. She noted that women with breast cancer have been shown to have a lower ratio of 2-hydroxyestrone to 16-alpha-hydroxyestrone than do healthy women. “We found that seaweed and soy favorably increased this ratio, and the increase in 2-hydroxyestrone was significant.”

The study also showed that for several variables, women who had been treated for breast cancer had different patterns of hormonal response than women who had never had breast cancer. Said Dr. Teas, “This suggests that diet after breast cancer treatment could be an important area for study.”

Related Videos
Exercise and healthy lifestyles can lower the risk of cancer or the symptoms of cancer treatment despite having genetic dispositions, said Neil M. Iyengar, MD.
The Hispanic Breast Cancer Clinic at Northwestern Memorial Hospital includes a social worker, nurse practitioners, a medical oncologist, a radiation oncologist, and surgeons, says Claudia Tellez, MD.
The goal of creating the Hispanic Breast Cancer Clinic at Northwestern Memorial Hospital is to establish a safe space for Hispanic patients, says Claudia Tellez, MD.
Several factors may contribute to the low Hispanic breast cancer population at Northwestern Memorial Hospital, including a lack of resources and a focus on other disease types.
Sara M. Tolaney, MD, MPH, an expert on breast cancer
Sara M. Tolaney, MD, MPH, an expert on breast cancer
Sara M. Tolaney, MD, MPH, an expert on breast cancer
Hypofractionated radiotherapy yields less financial toxicity than conventionally fractionated radiotherapy in patients with breast cancer who have undergone reconstruction following mastectomy.
Related Content